Results - Announcements
Kerala Ayurveda Ltd share price inched up 2.75% to Rs 167.85 after the company's net profit saw a mild growth of 9.19% to Rs 8.08 crore, while revenue from operations eased by 4.46% to Rs 33.19 crore in Q1FY27 over Q1FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, easing 5.84%. It has improved by 3.49% over last one week and ticked higher by 6.26% in last one month while the market capitalization of Kerala Ayurveda Ltd has increased 13.61% and 9.78% in the same period respectively.
Profit before tax (PBT) of Kerala Ayurveda Ltd stood at Rs 8.23 crore in Q1 FY27, tumbling by 392.88% year-on-year, and rising 3.13% quarter-on-quarter. EBITDA came in at Rs 4 crore, plunging by 70.06% YoY and crashing by 54.61% sequentially.
Total expenses reduced by 10.66% to Rs 38.89 crore in Q1FY27 over Q1FY26. During the quarter, cost of materials consumed stood at Rs 7.35 crore, growing marginally by 0.27% YoY, while employee benefits expense was at Rs 18.84 crore, slipping by 3.58% YoY.
For FY26, revenue from operations advanced 16.66% to Rs 120.33 crore, while net profit surged by 2392.86% to Rs 13.96 crore, compared to previous FY. EBITDA soared by 1007% to Rs 6.81 crore, and PBT tumbled by 1954.55% to Rs 12.24 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 4.83 crore in FY26, as against Rs 0.96 crore in FY25.
Kerala Ayurveda Ltd crashed 56.04% in last one year, underperforming the benchmark BSE Sensex which has slipped by 2.37% during the same period.